College of Medicine, Mayo Clinic, Rochester, MN, USA.
Med Sci Monit. 2010 Mar;16(3):CS29-32.
Adult polycystic kidney disease (ADPKD), an autosomal dominantly inherited cause of ESRD, is often characterized by a relative renal tubular unresponsiveness to ADH. Polyuria, renal concentrating defects and generally elevated ADH levels, a form of nephrogenic diabetes insipidus (NDI) is often implicated. Thus, even late in stages of CKD, ADPKD patients often produce significant amounts of urine. Conversely, central diabetes insipidus (CDI), a clinical syndrome secondary to deficiency of ADH, also leads to production of large volumes of dilute urine, i.e. polyuria. It is widely believed that clinical CDI is masked in ESRD patients on dialysis, due to apparently obvious reasons. However, there have been published a few reports of the unmasking of polyuria secondary to previously existing CDI in ESRD patients, after kidney transplantation.
We report, to our knowledge, the first case of new-onset symptomatic CDI causing nocturnal polyuria in an ADPKD patient with ESRD, before now on hemodialysis. CDI symptoms were noted, months after an intracranial aneurysm clipping procedure that was complicated by intra-cranial hemorrhage. The 59-year old Caucasian woman responded moderately to desmopressin replacement therapy.
Several interesting pathobiologic implications of this case report are entertained.
成人多囊肾病(ADPKD)是一种常染色体显性遗传导致的终末期肾病(ESRD)病因,其特点通常是肾远曲小管对血管加压素(ADH)相对无反应。多尿、肾脏浓缩功能障碍和一般升高的 ADH 水平,常提示存在肾性尿崩症(NDI)。因此,即使在 CKD 的晚期,ADPKD 患者通常也会产生大量尿液。相反,中枢性尿崩症(CDI)是由于 ADH 缺乏引起的临床综合征,也会导致大量稀释尿液的产生,即多尿。人们普遍认为,由于明显的原因,在透析的 ESRD 患者中,临床 CDI 是被掩盖的。然而,已经有一些关于在肾移植后,先前存在的 CDI 继发多尿的 ESRD 患者中 CDI 被揭示的报道。
我们报告了首例已知的新发性症状性 CDI 导致 ESRD 伴 ADPKD 患者夜间多尿的病例,在此之前,该患者一直在接受血液透析。在颅内动脉瘤夹闭术并伴有颅内出血后数月,患者出现 CDI 症状。这位 59 岁的白人女性对去氨加压素替代疗法有中度反应。
对该病例报告的几个有趣的病理生物学意义进行了探讨。